In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.

Source:http://linkedlifedata.com/resource/pubmed/id/10500201

Proc. Natl. Acad. Sci. U.S.A. 1999 Sep 28 96 20 11476-81

Download in:

View as

Triples

General Info

PMID
10500201